Perbedaan Fortune Mate Indonesia Tbk dan Tempo Scan Pacific Tbk.: Fortune Mate Indonesia Tbk diperdagangkan di Rp248 (kapitalisasi pasar 1,59 T, volume 24 jam 4,2 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 216,9 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 7,9× kapitalisasi pasar Fortune Mate Indonesia Tbk, dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (216,9 rb vs 4,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FMII | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 1,59 T | 12,58 T |
Volume | 4,2 rb | 216,9 rb |
Lot | 42 | 2,17 rb |
Perputaran | 1,04 jt | 599 jt |
Harga Rata-rata | 248 | 2.761,65 |
Nilai Transaksi | 1,04 jt | 599 jt |
Harga Ekuilibrium Indikatif | 248 | 2.790 |
Volume Ekuilibrium Indikatif | 200 | 3,9 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Selengkapnya di halaman FMII →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →